DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 93 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactOrders & Deals

Aptech Limited — Bagging/Receiving of orders/contracts

NSE 1 hr ago·9 Oct 2026, 4:02 pm

Aptech

Aptech Limited has informed exchanges that it has received new orders and contracts. This disclosure is made to comply with SEBI's regulations regarding the timely sharing of material information with the market.

For investors, this news signals potential revenue growth and operational expansion for the company. It indicates that the company is actively securing new business, which can be a positive indicator for its future financial performance and market position.

Investors should monitor the specific nature of these new contracts and the company's ability to execute them effectively. Keeping an eye on the company's quarterly results will help in understanding how these new orders are impacting its overall business growth.